Clarion 16 Cochlear Implant(System Introduction and Use Experience in Japan) System Introduction and Use Experience in Japan

The Clarion cochlear implant was developed in the USA and received FDA approval in August 1996. It consists of an implantable cochlear stimulator (ICS), speech processor with headpiece, and in addition, a clinician's programming system and portable cochlear implant tester. One of the features o...

Full description

Saved in:
Bibliographic Details
Published inNippon Jibi Inkoka Gakkai Kaiho Vol. 101; no. 5; pp. 578 - 585
Main Authors Kawano, Atsushi, Funasaka, Sotaro, Tomizawa, Ayako, Kato, Akio, Ueda, Hiroshi, Hakuhisa, Eiji, Sato, Chiho, Suzuki, Mamoru
Format Journal Article
LanguageEnglish
Japanese
Published Japan The Oto-Rhino-Laryngological Society of Japan, Inc 01.05.1998
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The Clarion cochlear implant was developed in the USA and received FDA approval in August 1996. It consists of an implantable cochlear stimulator (ICS), speech processor with headpiece, and in addition, a clinician's programming system and portable cochlear implant tester. One of the features of the device is its stimulationcoding process for which two methods of continuous interleaved sampling (CIS) and compressed analogue (CA) are applicable. Regardless of which is used, stimulation can be provided over 8 channels. The device was used in 2 cases. Both patients were operated on in October 1996, and 16 electrodes in 8 pairs were mounted in the cochlea. Mapping, performed 3 weeks after the operation, showed good speech perception in both patients with only a cochlear implant in the "open-set " status. CIS was used as the stimulation coding method. CA has yet to be applied.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Report-3
ObjectType-Case Study-4
ISSN:0030-6622
1883-0854
DOI:10.3950/jibiinkoka.101.5_578